Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

145 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2016-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate in a population of patients with septic shock receiving 500 ml crystalloid over 10 minutes, the proportion of patients classified as "responders" to the fluid challenge (increase of at least 15% of ITV in aortic) at the end of vascular filling (T10) and becoming "non-responders" 20 minutes after the end of the fluid challenge (T30) and whether this proportion is greater than 10 points.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock

NCT05094856

Septic Shock Sepsis

COMPLETED

Carotid Ultrasounds Measurements in Septic Shock

NCT05444621

Septic Shock

UNKNOWN

Ultrasound Optimization of Initial Fluid Challenge in Sepsis

NCT04028102

Sepsis

UNKNOWN

Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination

NCT02676427

Septic Shock Vein Collapsibility Intravascular Doppler +1 more

UNKNOWN

Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management

NCT06043505

Shock, Septic Hemodynamic Instability

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives of this study are :

A. To assess changes in different ultrasound parameters: E wave , E / A ratio , E / E ' in the event of vascular filling and construct a dose response curve for vascular filling.

B. To determing a threshold value for the mitral E wave velcoity that can predict a positive response to volume expansion at T10 defined by a 15% increase in the sub aortic velocity time integral (ITV) after 500 ml of crystalloids in 10 minutes.

C. To determine a threshold value for theITV at T0 that can predict a positive response to volume expansion at T10 defined by a 15% increase in the ITV after 500 ml of crystalloids in 10 minutes.

D. To evaluate the proportion of responders at T10 becoming non-responders at T20.

E. To evaluate the proportion of nonresponders at T10 and responders at T30 .

F. To estimate the proportion of patients changing status regardless of the direction of change between T10 and T30 .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Septic Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The study population

The study population consists of patients admitted to intensive care, sedated and under controlled ventilatory support with septic shock criteria defined by severe sepsis associated with hypotension despite fluid resuscitation of 20-40 ml / kg and requiring vascular filling according to the following criteria:

oliguria \<0.5 ml / kg / h for at least 2h skin mottling Arterial Lactate \> 2 mmol / l SvcO2 \<70% or SvO2 \<65% Patient on noradrenaline.

Severe sepsis is defined as a systemic inflammatory response associated with a suspected or proven infection and hypotension before filling, a lactate\> 4 mmol / l or organ dysfunction.

Intervention: Fluid challenge Intervention: Cardiac ultrasound

Fluid challenge

Intervention Type PROCEDURE

The fluid challenge starts at minute 0 (T0) and consists of 500ml of crystalloids over 10 minutes.

Cardiac ultrasound

Intervention Type PROCEDURE

Ultrasound measures are made at T0, T2, T4, T6, T8, T10, T20 and T30.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluid challenge

The fluid challenge starts at minute 0 (T0) and consists of 500ml of crystalloids over 10 minutes.

Intervention Type PROCEDURE

Cardiac ultrasound

Ultrasound measures are made at T0, T2, T4, T6, T8, T10, T20 and T30.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient has given his/hers consent or the patient is in an emergency situation (commitment to obtain the consent of the patient as soon as his/her condition permits)
* Patient affiliated or beneficiary of a health insurance plan
* Patient with septic shock: proven or suspected infection associated with hypotension or lactate\> 4 mmol / l or organ dysfunction. Hypotension despite fluid resuscitation of 20 to -40 ml / kg.
* Patient under controlled mechanical ventilation
* Patient requiring vascular filling according to the following criteria:
* oliguria \<0.5 ml / kg / h for at least 2h
* skin mottling
* Arterial Lactate \> 2 mmol / l
* SvcO2 \<70% or SvO2 \<65%
* Patient on noradrenaline.

Exclusion Criteria

* The patient is has in another interventional study that might change the results of this study within the past 3 months
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* The patient is pregnant, parturient, or breastfeeding
* Valvular pathology: grade III and IV aortic or mitral insufficiency
* Non sinus electrocardiogram
* Non-echogenic patient
* Patient with any spontaneous breathing
* Moribund patient

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No